Updated: Oct 16
Medically reviewed by ChinaCureLink Team
Table of Content
Introduction
Patients researching lung cancer or melanoma may encounter autologous natural tumor-infiltrating lymphocyte (TIL) therapy as an emerging cancer immunotherapy approach. In China, this treatment is available through a supervised medical-access pathway in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. This guide explains what the treatment is, who may be considered, its estimated cost, and what international patients should know before exploring treatment.
Key Takeaways |
|
What Is Autologous Natural TIL Therapy?
Autologous natural TIL therapy is a form of cancer immunotherapy that uses tumor-infiltrating lymphocytes, immune cells found within a patient's tumor. The cells are collected from the patient's own tumor, processed and expanded, and then prepared for administration back to the patient.
The GC101 Natural TIL Therapy product is described as a natural TIL therapy that does not require lymphocyte depletion or an interleukin-2 (IL-2) injection. The technology is being explored for solid tumors, including lung cancer and melanoma.
Clinical evidence for this treatment remains under evaluation. Its availability through a regulated medical-access pathway should not be interpreted as proof of effectiveness for an individual patient.
Lung Cancer TIL Therapy China: Is It Available?
Yes. Lung cancer TIL therapy China is available through the Hainan Boao Lecheng International Medical Tourism Pilot Zone's medical-access framework at the designated hospital.
This pathway is different from general nationwide approval for use throughout China. Treatment remains subject to applicable regulatory requirements, hospital procedures, and physician assessment. The treatment's safety and efficacy are still being evaluated, and patients should review the available clinical evidence and alternatives with qualified oncology specialists.
The treatment is therefore best understood as a specific pilot-zone access option rather than a therapy that is routinely available at hospitals throughout mainland China.
Where Is Lung Cancer TIL Therapy China Offered?
The treatment is offered at Hainan Haikong Le City Hospital (West China Le City Hospital of Sichuan University) in the Hainan Boao Lecheng Pilot Zone.
Technical support is provided by Shanghai Jun-Sai Biotechnology Co., Ltd. The product is GC101 Natural Tumor-Infiltrating Lymphocyte (TIL) Therapy, the same GC101 technology associated with another melanoma-focused listing at a different price.
Who May Be Eligible for Lung Cancer TIL Therapy China?
Eligibility begins with a confirmed diagnosis of lung cancer or melanoma established through cytological or histopathological examination.
The treatment is also subject to medical assessment because its safety and efficacy remain under evaluation. A diagnosis alone does not establish that an individual patient is suitable for treatment. The treating team may need to review the patient's medical history, pathology, previous treatments, current condition, and other clinical information before determining whether the treatment pathway can be considered.
Final eligibility is determined by the treating medical team after a face-to-face consultation or review of the patient's medical records.
How Much Does Lung Cancer TIL Therapy China Cost?
The estimated cost is ¥79,900 (approximately US$11,100) per treatment. The USD figure uses an illustrative conversion rate of about ¥7.2 per US$1 and is intended as a reference rather than a guaranteed exchange-rate calculation.
The stated treatment price does not necessarily include consultation, diagnostic testing, hospitalization, translation or coordination services, medication, or international travel. Patients should confirm the full scope of the quoted price and final treatment costs directly with the hospital before making travel arrangements.
Why International Patients May Consider This Option
For some international patients, access to an emerging cancer immunotherapy through a supervised medical pathway may provide another option to discuss with oncology specialists, particularly when evaluating treatment possibilities for lung cancer or melanoma.
The key consideration is not simply whether the treatment is available, but whether it is medically appropriate for the individual patient and how its potential benefits, risks, evidence, and alternatives compare with established treatment options. Patients should also understand that pilot-zone availability does not establish nationwide approval or guarantee a particular clinical outcome.
How ChinaCureLink Can Help Patients Access This Treatment
We help international patients explore available treatment options and facilitate communication with appropriate medical specialists. Patients should discuss potential benefits, risks, eligibility, and alternatives directly with qualified physicians. ChinaCureLink does not represent or endorse the treatment technology, manufacturer, or hospital.
Case review: We collect relevant medical history and lung cancer or melanoma-management records to help determine whether a case is appropriate for physician review.
Hospital coordination: We help connect patients with the treating team at Hainan Haikong Le City Hospital (West China Le City Hospital of Sichuan University) in China for an initial assessment.
Online consultation before travel: Patients can discuss potential eligibility, the procedure, and expected next steps with the medical team remotely before committing to international travel.
Coordination support: Depending on the case, this can include translation assistance, appointment scheduling, and logistics coordination.
Considering Lung Cancer TIL Therapy China?
Before planning travel, speak with a qualified specialist to determine whether the treatment is appropriate for your condition and whether you meet the medical eligibility requirements. ChinaCureLink can help international patients arrange a specialist review and explore the treatment pathway in China. [Request a Medical Review / Speak With a Specialist]
Get a Second Opinion Before Fly to China
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot
Medebound HEALTH's online testimonials. Learn More
★★★★☆ Sarah Zhang · Canada· Jul 2024 · Verified “The interpreter during the video call was fantastic — super professional and answered all our questions clearly and quickly. The professor was also very patient and gave us detailed and honest guidance on our treatment options.” |
★★★★★ Andrew Goh · Singapore · Aug 2024 · Verified “My first contact with Medebound was over a year ago. Jason has always been responsive, even when I wasn't ready to proceed. When I finally did, the consultation was seamlessly arranged and the specialist was outstanding.” |
★★★★★ Daniel Wong · Singapore · Aug 2024 · Verified “I have dry eye and nothing seemed to be working, even with different medications. I heard about a medication from the U.S. that’s supposed to be really effective, but I didn’t want to try it without talking to a doctor first. MEDEBOUND connected me with a top ophthalmologist in the U.S. and it was so reassuring to get their expert advice.” |
★★★★☆ Pongsakorn · Thailand · Feb 2025 · Verified “Kiki at Medebound is amazing — so professional and helpful! They got my video consultation with an MD Anderson expert set up super fast, within just 5 working days. I am so grateful for their support.” |
Frequently Asked Questions
Is lung cancer TIL therapy available in China?
Yes. Autologous natural TIL therapy for lung cancer is available through the Hainan Boao Lecheng Pilot Zone pathway at Hainan Haikong Le City Hospital, subject to medical evaluation and applicable requirements.
How much does TIL therapy cost in China?
The estimated cost is approximately US$11,100 (¥79,900) per treatment. Patients should confirm final pricing and exactly what is included with the hospital.
Who may qualify for natural TIL therapy?
Patients with lung cancer or melanoma confirmed through cytological or histopathological examination may be considered. Final eligibility is determined by the treating medical team after reviewing the patient's medical information.
Can international patients explore TIL therapy in Hainan?
International patients can explore the treatment pathway through the designated hospital and arrange a medical assessment before deciding whether to travel. Medical eligibility and treatment decisions must be determined by qualified physicians.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
